{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:50Z","timestamp":1787772170792,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40292-018-0275-y","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T07:19:40Z","timestamp":1533021580000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-4921","authenticated-orcid":false,"given":"Giuliano","family":"Tocci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Figliuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne","family":"Presta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Citoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Coluccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"issue":"9932","key":"275_CR1","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899\u2013911.","journal-title":"Lancet"},{"issue":"3","key":"275_CR2","first-page":"145","volume":"14","author":"G Tocci","year":"2007","unstructured":"Tocci G, Sciarretta S, Volpe M. Development of heart failure in hypertension: analysis of recent clinical trials. High Blood Press Cardiovasc Prev. 2007;14(3):145\u201396.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"4","key":"275_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/2048872616689773","volume":"6","author":"MF Piepoli","year":"2017","unstructured":"Piepoli MF, Corra U, Dendale P, Frederix I, Prescott E, Schmid JP, et al. Challenges in secondary prevention after acute myocardial infarction: a call for action. Eur Heart J Acute Cardiovasc Care. 2017;6(4):299\u2013310.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"10022","key":"275_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367.","journal-title":"Lancet"},{"issue":"8693","key":"275_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","volume":"335","author":"R Collins","year":"1990","unstructured":"Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827\u201338.","journal-title":"Lancet"},{"issue":"7","key":"275_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens"},{"issue":"21","key":"275_CR7","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","volume":"374","author":"EM Lonn","year":"2016","unstructured":"Lonn EM, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2009\u201320.","journal-title":"N Engl J Med"},{"issue":"6","key":"275_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/2047487315569401","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636\u201348.","journal-title":"Eur J Prev Cardiol"},{"issue":"218","key":"275_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2016.05.044","volume":"01","author":"C Borghi","year":"2016","unstructured":"Borghi C, Tubach F, De Backer G, Dallongeville J, Guallar E, Medina J, et al. Lack of control of hypertension in primary cardiovascular disease prevention in Europe: results from the EURIKA study. Int J Cardiol. 2016;01(218):83\u20138.","journal-title":"Int J Cardiol"},{"issue":"6","key":"275_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/clc.22955","volume":"41","author":"I Figliuzzi","year":"2018","unstructured":"Figliuzzi I, Presta V, Citoni B, Miceli F, Simonelli F, Battistoni A, et al. Achievement of multiple therapeutic targets for cardiovascular disease prevention: retrospective analysis of real practice in Italy. Clin Cardiol. 2018;41(6):788\u201396. \n                    https:\/\/doi.org\/10.1002\/clc.22955\n                    \n                  .","journal-title":"Clin Cardiol"},{"issue":"7291","key":"275_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/bmj.322.7291.912","volume":"322","author":"G Beevers","year":"2001","unstructured":"Beevers G, Lip GY, O\u2019Brien E. ABC of hypertension: the pathophysiology of hypertension. BMJ. 2001;322(7291):912\u20136.","journal-title":"BMJ"},{"issue":"1","key":"275_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/157340308783565456","volume":"4","author":"L Khalid","year":"2008","unstructured":"Khalid L, Dhakam SH. A review of cardiogenic shock in acute myocardial infarction. Curr Cardiol Rev. 2008;4(1):34\u201340.","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"275_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jacc.2004.03.060","volume":"44","author":"R Fincke","year":"2004","unstructured":"Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44(2):340\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"275_CR14","first-page":"1226","volume":"25","author":"D Chin","year":"2012","unstructured":"Chin D, Battistoni A, Tocci G, Passerini J, Parati G, Volpe M. Non-invasive diagnostic testing for coronary artery disease in the hypertensive patient: potential advantages of a risk estimation-based algorithm. Am J Hypertens. 2012;25(12):1226\u201335.","journal-title":"Am J Hypertens"},{"issue":"3","key":"275_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40292-013-0020-5","volume":"20","author":"M Volpe","year":"2013","unstructured":"Volpe M, Trimarco B, Battistoni A, Mancia G, Italian Society of H. Clinical management of coronary heart disease in hypertension : practical recommendations from the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev. 2013;20(3):129\u201334.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"5","key":"275_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jcin.2014.01.157","volume":"7","author":"F Radico","year":"2014","unstructured":"Radico F, Cicchitti V, Zimarino M, De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv. 2014;7(5):453\u201363.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"275_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cjca.2012.10.022","volume":"29","author":"T Dowsley","year":"2013","unstructured":"Dowsley T, Al-Mallah M, Ananthasubramaniam K, Dwivedi G, McArdle B, Chow BJ. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Can J Cardiol. 2013;29(3):285\u201396.","journal-title":"Can J Cardiol"},{"issue":"22","key":"275_CR18","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1161\/hc4701.099731","volume":"104","author":"Y Fu","year":"2001","unstructured":"Fu Y, Goodman S, Chang WC, Van De Werf F, Granger CB, Armstrong PW. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation. 2001;104(22):2653\u20139.","journal-title":"Circulation"},{"key":"275_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.phrs.2018.02.026","volume":"130","author":"M Salvetti","year":"2018","unstructured":"Salvetti M, Paini A, Bertacchini F, Stassaldi D, Aggiusti C, Agabiti Rosei C, Muiesan ML. Acute blood pressure elevation: therapeutic approach. Pharmacol Res. 2018;130:180\u201390. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2018.02.026\n                    \n                  .","journal-title":"Pharmacol Res"},{"issue":"2","key":"275_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"3","key":"275_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"6709","key":"275_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/bmj.299.6709.1187","volume":"299","author":"PH Held","year":"1989","unstructured":"Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989;299(6709):1187\u201392.","journal-title":"BMJ"},{"issue":"16","key":"275_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1001\/jama.1996.03540160050032","volume":"276","author":"E Grossman","year":"1996","unstructured":"Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276(16):1328\u201331.","journal-title":"JAMA"},{"issue":"8951","key":"275_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","author":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group","year":"1995","unstructured":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345(8951):669\u201385.","journal-title":"Lancet"},{"issue":"217","key":"275_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2016.04.132","volume":"15","author":"F Ricci","year":"2016","unstructured":"Ricci F, Di Castelnuovo A, Savarese G, Perrone Filardi P, De Caterina R. ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure\u2014a network meta-analysis. Int J Cardiol. 2016;15(217):128\u201334.","journal-title":"Int J Cardiol"},{"issue":"3","key":"275_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2165\/0151642-200815030-00009","volume":"15","author":"M Volpe","year":"2008","unstructured":"Volpe M, Tocci G, Trimarco B, Mancia G. Angiotensin II receptor blockers and risk of myocardial infarction: a meta-analysis of randomized clinical trials updated until May 1, 2008. High Blood Press Cardiovasc Prev. 2008;15(3):171\u2013215.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"9","key":"275_CR27","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.amjcard.2016.07.074","volume":"118","author":"C Bavishi","year":"2016","unstructured":"Bavishi C, Ahmed M, Trivedi V, Khan AR, Gongora C, Bangalore S, et al. Meta-analysis of randomized trials on the efficacy and safety of angiotensin-converting enzyme inhibitors in patients >\/=65 years of age. Am J Cardiol. 2016;118(9):1427\u201336.","journal-title":"Am J Cardiol"},{"issue":"12","key":"275_CR28","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1097\/HJH.0b013e328010b8f3","volume":"24","author":"EA Rosei","year":"2006","unstructured":"Rosei EA, Salvetti M, Farsang C. European Society of Hypertension Scientific Newsletter: treatment of hypertensive urgencies and emergencies. J Hypertens. 2006;24(12):2482\u20135.","journal-title":"J Hypertens"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-018-0275-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0275-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0275-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T19:13:43Z","timestamp":1564514023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-018-0275-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1007\/s40292-018-0275-y","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"15 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors have no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain data derived by any current studies with human participants performed by any of the authors. The clinical studies mentioned were provided with specific ethical approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}